510(k) Report

510(k) · Cleared

Cleared

MDx-Chex for BCID2

K212576510(k) TraditionalCleared Jan 19, 2022156-day reviewClass II21 CFR 866.3920

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Streck, Inc. · PMN Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays

Cleared on Jan 19, 2022 as substantially equivalent to K200010 (Maine Molecular Quality Controls, Inc., 2020) after a 156-day review. Its family tree reaches back 4 generations to 2016. 5 later devices descend from it.

Decided
Jan 19, 2022
Review
156 days
Class
Class II
Product code
PMN
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to DEN150058 (2016). 5 later devices descend from it, 3 citing it directly.

  1. Root · 4 generations backDEN150058 Amplichek II, Negative and Amplichek II, Negative MiniPak, Amplichek…Bio-Rad Laboratories · 2016
  2. 3 generations backK161573 FilmArray RP EZ Control Panel M265Maine Molecular Quality Controls, Inc. · 2016
  3. 2 generations backK190222 FilmArray Pneumonia/Pneumoniaplus ControlMaine Molecular Quality Controls, Inc. · 2019
  4. 1 generation backK200010 FilmArray BCID2 Control Panel M416Maine Molecular Quality Controls, Inc. · 2020
  5. This deviceK212576 MDx-Chex for BCID2Streck, Inc. · 2022
  6. Descendant · cites it directly · 1 of its ownK231221 MDx-Chex for BC-GPStreck · 2023
  7. Descendant · cites it directly · 1 of its ownK231223 MDx-Chex for BC-GNStreck · 2023
  8. Descendant · 2 generations on · 0 of its ownK260041 MDx-Chex for BCPStreck, LLC · 2026
  9. Descendant · 2 generations on · 0 of its ownK254166 MDx-Chex for BCNStreck · 2026
  10. Descendant · cites it directly · 0 of its ownK254167 MDx-Chex for BCYStreck, LLC · 2026

Most influential descendants

Showing 5 of 5 · See all
  • K231221MDx-Chex for BC-GPStreck · 2023 · cites it directly1descendant
  • K231223MDx-Chex for BC-GNStreck · 2023 · cites it directly1descendant
  • K260041MDx-Chex for BCPStreck, LLC · 2026 · 2 generations on0descendants
  • K254166MDx-Chex for BCNStreck · 2026 · 2 generations on0descendants
  • K254167MDx-Chex for BCYStreck, LLC · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4DEN150058Amplichek II, Negative and Amplichek II, Negative MiniPak, Amplichek II, Level…Bio-Rad Laboratories2016—
−3K161573FilmArray RP EZ Control Panel M265Maine Molecular Quality Controls, Inc.2016—
−2K190222FilmArray Pneumonia/Pneumoniaplus ControlMaine Molecular Quality Controls, Inc.2019—
−1K200010FilmArray BCID2 Control Panel M416Maine Molecular Quality Controls, Inc.2020—
0 (this device)K212576MDx-Chex for BCID2Streck, Inc.2022—
+1K231221MDx-Chex for BC-GPStreck2023—
+1K231223MDx-Chex for BC-GNStreck2023—
+2K260041MDx-Chex for BCPStreck, LLC2026—
+2K254166MDx-Chex for BCNStreck2026—
+1K254167MDx-Chex for BCYStreck, LLC2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202320
202630
FIG. 1 — Lineage of K212576, 2016–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PMN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PMN device

  1. #1 K251526 FilmArray GI Control Panel M238score 13.7 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K200010FilmArray BCID2 Control Panel M416
Summary page 4
…assays Product Code: PMN (866.3920) Panel Microbiology Predicate Device: K200010-Maine Molecular FilmArray BCID2 Control Panel M416 Device Description MDx-Chex for BCID2 Control 1 - GN is positive for certain…
Maine Molecular Quality Controls, Inc.2020—

Also cleared against K200010: 1 other device →

What descends from it? (5)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K231221MDx-Chex for BC-GPStreck20231
K231223MDx-Chex for BC-GNStreck20231
K254167MDx-Chex for BCYStreck, LLC20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 6 years and passes through 3 companies; a new generation was cleared every 1.8 years on median.
  • None of the 4 ancestors has a recall.
  • Of its descendants, K231221 (Streck, 2023) has gone furthest, with 1 descendant of its own.
  • 1 other device also cites its predicate K200010.

How does its category compare?

All PMN devices

PMN Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · PMN

1in 2025

2016: 32017: 22018: 32019: 62020: 22021: 12022: 32023: 42024: 22025: 12026 (partial year): 6
2007high 6 (2019) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PMN

90in 2023

2018: 59 days median2019: 71 days median2022: 582 days median2023: 90 days median2026 (partial year): 85 days median
2007high 582 (2022) · low 59 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PMN

1in 2019

2019: 1
2007high 1 (2019) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PMN

1in 2023

2023: 1
2007high 1 (2023) · low 0 (2007)2025

MAUDE reports naming product code PMN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20163—00
20172—00
201835900
201967110
20202—00
20211—00
2022358200
202349001
20242—00
20251—00
20266850—

What is it indicated for?

MDx-Chex for BCID2 is intended for use as an external positive and negative assayed control to monitor the performance of the qualitative detection of yeast, Gram positive and Gram negative bacteria, as well as associated antimicrobial resistance genes, by the BioFire FilmArray Blood Culture Identification 2 (BCID2) Panel on FilmArray systems. Control 1 - GN: Gram negative bacteria: Acinetobacter colcoaceticus-baumannii complex, Bacteroides fragilis…

Read the full statement (160 words)

MDx-Chex for BCID2 is intended for use as an external positive and negative assayed control to monitor the performance of the qualitative detection of yeast, Gram positive and Gram negative bacteria, as well as associated antimicrobial resistance genes, by the BioFire FilmArray Blood Culture Identification 2 (BCID2) Panel on FilmArray systems. Control 1 - GN: Gram negative bacteria: Acinetobacter colcoaceticus-baumannii complex, Bacteroides fragilis, Enterobacter cloacae complex, Escherichia coli, Klebsiella aerogenes, Klebsiella oxytoca, Klebsiella pneumoniae group, Proteus spp., Salmonella spp., Serratia marcescens, Haemophilus influenza, Neisseria meningitides, Pseudomonas aeruginosa, Stenotrophomonas maltophilia; antimicrobial resistance genes: KPC, CTX-M, IMP, NDM, OXA-48-like, VIM, mcr- 1. Control 2 - GPY: Gram positive bacteria: Enterococcus Jaecalis, Enterococcus faecium, Listeria monocytogenes, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus lugdunesis, Streptococcus agalactiae, Streptococcus pneumonia, Streptococcus pyogenes; yeast: Candida albicans, Candida auris, Candida glabrata, Candida krusei, Candida parapsilosis, Candida tropicalis, Cryptococcus neoformans/gatti; antimicrobial resistance genes mecA/C and MREJ, vanA/B. This product is not intended to replace manufacturer controls provided with the device.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K212576: MDx-Chex for BCID2.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K212576

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026